Current Medical Research and Opinion, Volume 34, Issue 4 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Current Medical Research and Opinion, Volume 34, Issue 4 (2018)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Volume 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Vol 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Neurotherapeutics & Pain

Addiction

Report
Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations
George K. Avetian, Phillip Fiuty, Silvana Mazzella, Dave Koppa, Vivian Heye & Pratibha Hebbar
Pages: 573-576
Published online: 07 Jun 2017
AbstractforUse of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations | Full Text | References | PDF (444.2 KB)
  • 2028 Views
  • 25 CrossRef citations
  • 0Altmetric

Gastrointestinal

Article
Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists
Eline Houben, Saga Johansson, Péter Nagy, Fernie J. A. Penning-van Beest, Ernst J. Kuipers & Ron M. C. Herings
Pages: 577-583
Published online: 24 Nov 2017
AbstractforObservational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists | Full Text | References | PDF (735.3 KB) | Supplemental
  • 460 Views
  • 5 CrossRef citations
  • 0Altmetric

Neurotherapeutics

Article
Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States
Zhou Zhou, Zheng-Yi Zhou, Sneha S. Kelkar, Vanja Sikirica, Jipan Xie & Regina Grebla
Pages: 585-592
Published online: 08 Dec 2017
AbstractforMedication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States | Full Text | References | PDF (1 MB) | Supplemental
  • 851 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome
Michael Cronquist Christensen & Vicki Munro
Pages: 593-600
Published online: 16 Jan 2018
AbstractforCost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome | Full Text | References | PDF (717 KB)
  • 1130 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates
Solomon Nuhoho, Abdallah Saad, Goretti Saumell, Daniel Ribes & Antoine C. El Khoury
Pages: 601-611
Published online: 10 Jan 2018
AbstractforEconomic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates | Full Text | References | PDF (1.2 MB) | Supplemental
  • 342 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia
David J. Castle & Eric Chung
Pages: 613-618
Published online: 08 Jan 2018
AbstractforCardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia | Full Text | References | PDF (733.7 KB)
  • 733 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine
Cliff Molife, Virginia S. Haynes, Allen Nyhuis, Douglas E. Faries, Steve Gelwicks, Douglas K. Kelsey & Carlos I. Alatorre
Pages: 619-632
Published online: 05 Feb 2018
AbstractforHealthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine | Full Text | References | PDF (1.2 MB) | Supplemental
  • 273 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
Mary Hobart, Aleksandar Skuban, Peter Zhang, Mette Krog Josiassen, Nanco Hefting, Carole Augustine, Claudette Brewer, Raymond Sanchez & Robert D. McQuade
Pages: 633-642
Published online: 25 Jan 2018
AbstractforEfficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study | Full Text | References | PDF (1.2 MB)
  • 5256 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Article
Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States
Victor W. Sung, Ravi G. Iyer, Sanjay K. Gandhi, Bijal Shah-Manek, Marco DiBonaventura, Victor Abler & Daniel O. Claassen
Pages: 643-648
Published online: 16 Feb 2018
AbstractforPhysician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States | Full Text | References | PDF (1.1 MB) | Supplemental
  • 321 Views
  • 5 CrossRef citations
  • 0Altmetric

Obstetrics

Article
Continuous epidural infusion versus programmed intermittent epidural bolus for labor analgesia: optimal configuration of parameters to reduce physician-administered top-ups
Carlos Delgado, Christopher Ciliberto, Laurent Bollag, Margaret Sedensky & Ruth Landau
Pages: 649-656
Published online: 06 Oct 2017
AbstractforContinuous epidural infusion versus programmed intermittent epidural bolus for labor analgesia: optimal configuration of parameters to reduce physician-administered top-ups | Full Text | References | PDF (1.1 MB) | Supplemental
  • 700 Views
  • 22 CrossRef citations
  • 0Altmetric

Pain

Article
Sensory symptoms in low back pain—how do they matter?
Janne Gierthmühlen, Jessica Greinacher, Johanna Höper, Violetta Oberlojer, Michael Lankes, Frieder Traulsen, Philipp Hüllemann, Christoph Borzikowsky, Maren Reimer & Ralf Baron
Pages: 657-667
Published online: 24 Aug 2017
AbstractforSensory symptoms in low back pain—how do they matter? | Full Text | References | PDF (1.4 MB) | Supplemental
  • 252 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Understanding the different relationships between mood and sleep disorders in several groups of non-oncological patients with chronic pain
B. Ojeda, A. Salazar, M. J. Calahorro, M. Dueñas, J. A. Mico, H. de Sola & I. Failde
Pages: 669-676
Published online: 25 Oct 2017
AbstractforUnderstanding the different relationships between mood and sleep disorders in several groups of non-oncological patients with chronic pain | Full Text | References | PDF (1.1 MB)
  • 246 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Is there a role for combined use of gabapentin and pregabalin in pain control? Too good to be true?
Helen Senderovich & Geetha Jeyapragasan
Pages: 677-682
Published online: 04 Dec 2017
AbstractforIs there a role for combined use of gabapentin and pregabalin in pain control? Too good to be true? | Full Text | References | PDF (692.7 KB)
  • 4667 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Absorption of ibuprofen orodispersible tablets in early postoperative phase – a pharmacokinetic study
A. Piirainen, M. Kokki, H. M. Lidsle, M. Lehtonen, V. P. Ranta & H. Kokki
Pages: 683-688
Published online: 03 Nov 2017
AbstractforAbsorption of ibuprofen orodispersible tablets in early postoperative phase – a pharmacokinetic study | Full Text | References | PDF (599.1 KB)
  • 199 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study
Kenneth Reed, Agron Collaku & Sebastian Moreira
Pages: 689-699
Published online: 11 Jan 2018
AbstractforEfficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study | Full Text | References | PDF (945.3 KB)
  • 623 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study
Manuel Jesús Rodríguez, Rosalía de la Torre, Josefa Luisa Ortega, José Manuel Trinidad, Diego Benítez, Antonio Javier Jiménez, Almudena Sanz-Yagüe, Begoña Soler & Luis Miguel Torres
Pages: 701-709
Published online: 12 Oct 2017
AbstractforEvaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study | Full Text | References | PDF (932.9 KB)
  • 284 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Abuse-deterrent opioids: an update on current approaches and considerations
Joseph V. Pergolizzi Jr, Robert B. Raffa, Robert Taylor Jr & Steven Vacalis
Pages: 711-723
Published online: 10 Jan 2018
AbstractforAbuse-deterrent opioids: an update on current approaches and considerations | Full Text | References | PDF (1.7 MB)
  • 2304 Views
  • 24 CrossRef citations
  • 0Altmetric

Psychiatry

Review
Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies
Chris Cameron, Jacqueline Zummo, Dharmik Desai, Christine Drake, Brian Hutton, Ahmed Kotb & Peter J. Weiden
Pages: 725-733
Published online: 10 Jan 2018
AbstractforEfficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies | Full Text | References | PDF (1.5 MB) | Supplemental
  • 615 Views
  • 4 CrossRef citations
  • 0Altmetric

Rheumatology

Article
Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study
Yi-Yun Lee, Chao-Hsiun Tang, Jin-Hua Chen, Li-Na Kuo & Yu Ko
Pages: 735-740
Published online: 16 Jan 2018
AbstractforEvaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study | Full Text | References | PDF (602.7 KB)
  • 226 Views
  • 5 CrossRef citations
  • 0Altmetric

Virology

Article
Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant
Jianbin Mao, Jeffrey T. McPheeters, Dongmu Zhang, Camilo J. Acosta & Lynn Finelli
Pages: 741-749
Published online: 25 Oct 2017
AbstractforHerpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant | Full Text | References | PDF (910.8 KB) | Supplemental
  • 371 Views
  • 5 CrossRef citations
  • 0Altmetric

Gastroenterology

Report
Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study
Charles F. Barish & Patrick Griffin
Pages: 751-755
Published online: 02 Feb 2018
AbstractforSafety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study | Full Text | References | PDF (544 KB)
  • 633 Views
  • 18 CrossRef citations
  • 0Altmetric

Explore articles